{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T10:30:14Z","timestamp":1785925814791,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Data on the association between aspirin and statin use and Pancreatic Ductal AdenoCarcinoma (PDAC) risk are conflicting. These drugs are often co-prescribed, but no studies evaluated the potential combined or confounding effect of the two at the same time. We aimed to investigate the association between aspirin and statin exclusive and combined use and PDAC occurrence. Data on environmental factors, family and medical history were screened in a case-control study. PDAC cases were matched to controls for age and gender. Power calculation performed ahead. Odds ratios (OR) and 95% confidence intervals(CI) were obtained from multivariable logistic regression analysis. In 408 PDAC patients and 816 matched controls, overall statin (OR 0.61; 95%CI,0.43\u20130.88), but not aspirin use was associated to reduced PDAC risk. Compared to non-users, exclusive statin (OR 0.51; 95%CI,0.32\u20130.80) and exclusive aspirin users (OR 0.64; 95%CI,0.40\u20131.01) had reduced PDAC risk. Concomitant statin and aspirin use did not further reduce the risk compared with statin use alone and no interaction was evident. Statin protective association was dose-dependent, and consistent in most subgroups, being stronger in smokers, elderly, obese and non-diabetic patients. The present study suggests that statin use is associated to reduced PDAC risk, supporting a chemopreventive action of statins on PDAC.<\/jats:p>","DOI":"10.1038\/s41598-017-13430-z","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T09:53:38Z","timestamp":1507283618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study"],"prefix":"10.1038","volume":"7","author":[{"given":"Livia","family":"Archibugi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Piciucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Stigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Zerboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Barucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Milella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Delle Fave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Capurso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"13430_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA: a cancer journal for clinicians \n                           63, 11\u201330, https:\/\/doi.org\/10.3322\/caac.21166 (2013).","journal-title":"CA: a cancer journal for clinicians"},{"key":"13430_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research \n                           74, 2913\u20132921, https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155 (2014).","journal-title":"Cancer research"},{"key":"13430_CR3","first-page":"312","volume":"7","author":"K Spanknebel","year":"2001","unstructured":"Spanknebel, K. & Conlon, K. C. Advances in the surgical management of pancreatic cancer. Cancer journal \n                           7, 312\u2013323 (2001).","journal-title":"Cancer journal"},{"key":"13430_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pharmthera.2015.08.006","volume":"155","author":"C Neuzillet","year":"2015","unstructured":"Neuzillet, C. et al. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacology & therapeutics \n                           155, 80\u2013104, https:\/\/doi.org\/10.1016\/j.pharmthera.2015.08.006 (2015).","journal-title":"Pharmacology & therapeutics"},{"key":"13430_CR5","doi-asserted-by":"publisher","unstructured":"Canto, M. I. et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology \n                           142, 796\u2013804; quiz e714\u2013795, https:\/\/doi.org\/10.1053\/j.gastro.2012.01.005 (2012).","DOI":"10.1053\/j.gastro.2012.01.005"},{"key":"13430_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ije\/dyu240","volume":"44","author":"P Maisonneuve","year":"2015","unstructured":"Maisonneuve, P. & Lowenfels, A. B. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. International journal of epidemiology \n                           44, 186\u2013198, https:\/\/doi.org\/10.1093\/ije\/dyu240 (2015).","journal-title":"International journal of epidemiology"},{"key":"13430_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamaoncol.2015.6396","volume":"2","author":"Y Cao","year":"2016","unstructured":"Cao, Y. et al. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. JAMA oncology \n                           2, 762\u2013769, https:\/\/doi.org\/10.1001\/jamaoncol.2015.6396 (2016).","journal-title":"JAMA oncology"},{"key":"13430_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo, K. & Force, U. S. P. S. T. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of internal medicine \n                           164, 836\u2013845, https:\/\/doi.org\/10.7326\/M16-0577 (2016).","journal-title":"Annals of internal medicine"},{"key":"13430_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/apt.13857","volume":"45","author":"L Emilsson","year":"2017","unstructured":"Emilsson, L. et al. Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention. Alimentary pharmacology & therapeutics \n                           45, 193\u2013204, https:\/\/doi.org\/10.1111\/apt.13857 (2017).","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"13430_CR10","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.2174\/09298673113209990196","volume":"20","author":"X Shen","year":"2013","unstructured":"Shen, X. et al. Aspirin: a potential therapeutic approach in pancreatic cancer. Current medicinal chemistry \n                           20, 4153\u20134162 (2013).","journal-title":"Current medicinal chemistry"},{"key":"13430_CR11","doi-asserted-by":"publisher","unstructured":"Din, F. V. et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology \n                           142, 1504\u20131515 e1503, https:\/\/doi.org\/10.1053\/j.gastro.2012.02.050 (2012).","DOI":"10.1053\/j.gastro.2012.02.050"},{"key":"13430_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/1940-6207.CAPR-13-0337","volume":"7","author":"W Yue","year":"2014","unstructured":"Yue, W., Yang, C. S., DiPaola, R. S. & Tan, X. L. Repurposing of metformin and aspirin by targeting AMPK-mTOR and inflammation for pancreatic cancer prevention and treatment. Cancer prevention research \n                           7, 388\u2013397, https:\/\/doi.org\/10.1158\/1940-6207.CAPR-13-0337 (2014).","journal-title":"Cancer prevention research"},{"key":"13430_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep15460","volume":"5","author":"YP Zhang","year":"2015","unstructured":"Zhang, Y. P., Wan, Y. D., Sun, Y. L., Li, J. & Zhu, R. T. Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies. Scientific reports \n                           5, 15460, https:\/\/doi.org\/10.1038\/srep15460 (2015).","journal-title":"Scientific reports"},{"key":"13430_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0578-1","volume":"18","author":"PE Miller","year":"2016","unstructured":"Miller, P. E. & Martin, S. S. Approach to Statin Use in 2016: an Update. Current atherosclerosis reports \n                           18, 20, https:\/\/doi.org\/10.1007\/s11883-016-0578-1 (2016).","journal-title":"Current atherosclerosis reports"},{"key":"13430_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1677\/ERC-10-0009","volume":"17","author":"C Laezza","year":"2010","unstructured":"Laezza, C. et al. Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. Endocrine-related cancer \n                           17, 495\u2013503, https:\/\/doi.org\/10.1677\/ERC-10-0009 (2010).","journal-title":"Endocrine-related cancer"},{"key":"13430_CR16","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/1055-9965.EPI-05-0027","volume":"14","author":"RE Duncan","year":"2005","unstructured":"Duncan, R. E., El-Sohemy, A. & Archer, M. C. Statins and cancer development. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology \n                           14, 1897\u20131898, https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0027 (2005).","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"13430_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3892\/ijo.2011.1273","volume":"40","author":"C Spampanato","year":"2012","unstructured":"Spampanato, C. et al. Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression. International journal of oncology \n                           40, 935\u2013941, https:\/\/doi.org\/10.3892\/ijo.2011.1273 (2012).","journal-title":"International journal of oncology"},{"key":"13430_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc1751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre, M. F., Higgins, P. D., Gruber, S. B., Hawk, E. & Lippman, S. M. Statins and cancer prevention. Nature reviews. Cancer \n                           5, 930\u2013942, https:\/\/doi.org\/10.1038\/nrc1751 (2005).","journal-title":"Nature reviews. Cancer"},{"key":"13430_CR19","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/156800905774932824","volume":"5","author":"J Dulak","year":"2005","unstructured":"Dulak, J. & Jozkowicz, A. Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy. Current cancer drug targets \n                           5, 579\u2013594 (2005).","journal-title":"Current cancer drug targets"},{"key":"13430_CR20","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s40265-014-0309-2","volume":"74","author":"S Bonovas","year":"2014","unstructured":"Bonovas, S. Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes? Drugs \n                           74, 1841\u20131848, https:\/\/doi.org\/10.1007\/s40265-014-0309-2 (2014).","journal-title":"Drugs"},{"key":"13430_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10552-013-0326-6","volume":"25","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies. Cancer causes & control: CCC \n                           25, 237\u2013249, https:\/\/doi.org\/10.1007\/s10552-013-0326-6 (2014).","journal-title":"Cancer causes & control: CCC"},{"key":"13430_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2036.2012.05194.x","volume":"36","author":"L Alexandre","year":"2012","unstructured":"Alexandre, L., Clark, A. B., Cheong, E., Lewis, M. P. & Hart, A. R. Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma. Alimentary pharmacology & therapeutics \n                           36, 301\u2013311, https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05194.x (2012).","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"13430_CR23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s10552-012-9979-9","volume":"23","author":"X Cui","year":"2012","unstructured":"Cui, X. et al. Statin use and risk of pancreatic cancer: a meta-analysis. Cancer causes & control: CCC \n                           23, 1099\u20131111, https:\/\/doi.org\/10.1007\/s10552-012-9979-9 (2012).","journal-title":"Cancer causes & control: CCC"},{"key":"13430_CR24","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/cncr.29256","volume":"121","author":"EJ Walker","year":"2015","unstructured":"Walker, E. J., Ko, A. H., Holly, E. A. & Bracci, P. M. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study. Cancer \n                           121, 1287\u20131294, https:\/\/doi.org\/10.1002\/cncr.29256 (2015).","journal-title":"Cancer"},{"key":"13430_CR25","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1007\/s10620-013-2778-7","volume":"58","author":"FJ Carey","year":"2013","unstructured":"Carey, F. J. et al. The differential effects of statins on the risk of developing pancreatic cancer: a case-control study in two centres in the United Kingdom. Digestive diseases and sciences \n                           58, 3308\u20133312, https:\/\/doi.org\/10.1007\/s10620-013-2778-7 (2013).","journal-title":"Digestive diseases and sciences"},{"key":"13430_CR26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/ijc.22796","volume":"121","author":"M Hoffmeister","year":"2007","unstructured":"Hoffmeister, M., Chang-Claude, J. & Brenner, H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. International journal of cancer \n                           121, 1325\u20131330, https:\/\/doi.org\/10.1002\/ijc.22796 (2007).","journal-title":"International journal of cancer"},{"key":"13430_CR27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ypmed.2003.11.027","volume":"38","author":"G Corrao","year":"2004","unstructured":"Corrao, G., Bagnardi, V., Zambon, A. & La Vecchia, C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Preventive medicine \n                           38, 613\u2013619, https:\/\/doi.org\/10.1016\/j.ypmed.2003.11.027 (2004).","journal-title":"Preventive medicine"},{"key":"13430_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.dld.2007.05.006","volume":"39","author":"C Loguercio","year":"2007","unstructured":"Loguercio, C. et al. Drinking habits and risk of altered liver enzymes in the general population of a rural area in Southern Italy. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver \n                           39, 748\u2013752, https:\/\/doi.org\/10.1016\/j.dld.2007.05.006 (2007).","journal-title":"Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"13430_CR29","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","volume":"68","author":"P Patrignani","year":"2016","unstructured":"Patrignani, P. & Patrono, C. Aspirin and Cancer. Journal of the American College of Cardiology \n                           68, 967\u2013976, https:\/\/doi.org\/10.1016\/j.jacc.2016.05.083 (2016).","journal-title":"Journal of the American College of Cardiology"},{"key":"13430_CR30","doi-asserted-by":"publisher","unstructured":"Lafeber, M. et al. The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease. American heart journal \n                           166, 282\u2013289 e281, https:\/\/doi.org\/10.1016\/j.ahj.2013.04.011 (2013).","DOI":"10.1016\/j.ahj.2013.04.011"},{"key":"13430_CR31","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10552-016-0717-6","volume":"27","author":"MS Simon","year":"2016","unstructured":"Simon, M. S. et al. Prospective analysis of association between statins and pancreatic cancer risk in the Women\u2019s Health Initiative. Cancer causes & control: CCC \n                           27, 415\u2013423, https:\/\/doi.org\/10.1007\/s10552-016-0717-6 (2016).","journal-title":"Cancer causes & control: CCC"},{"key":"13430_CR32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10552-016-0824-4","volume":"27","author":"PF Kho","year":"2016","unstructured":"Kho, P. F. et al. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study. Cancer causes & control: CCC \n                           27, 1457\u20131464, https:\/\/doi.org\/10.1007\/s10552-016-0824-4 (2016).","journal-title":"Cancer causes & control: CCC"},{"key":"13430_CR33","doi-asserted-by":"publisher","unstructured":"Liu, J. C. et al. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study. Oncotarget, https:\/\/doi.org\/10.18632\/oncotarget.11162 (2016).","DOI":"10.18632\/oncotarget.11162"},{"key":"13430_CR34","doi-asserted-by":"publisher","unstructured":"Hermann, P. C. et al. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Gastroenterology \n                           147, 1119\u20131133 e1114, https:\/\/doi.org\/10.1053\/j.gastro.2014.08.002 (2014).","DOI":"10.1053\/j.gastro.2014.08.002"},{"key":"13430_CR35","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/ijc.27456","volume":"131","author":"A Mohammed","year":"2012","unstructured":"Mohammed, A. et al. Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3\/AKT signaling in p48Cre\/+ LSL-KrasG12D\/+ mice. International journal of cancer \n                           131, 1951\u20131962, https:\/\/doi.org\/10.1002\/ijc.27456 (2012).","journal-title":"International journal of cancer"},{"key":"13430_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biopha.2015.12.017","volume":"78","author":"M Tsubaki","year":"2016","unstructured":"Tsubaki, M. et al. Statins inhibited the MIP-1alpha expression via inhibition of Ras\/ERK and Ras\/Akt pathways in myeloma cells. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie \n                           78, 23\u201329, https:\/\/doi.org\/10.1016\/j.biopha.2015.12.017 (2016).","journal-title":"Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie"},{"key":"13430_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ijc.29813","volume":"138","author":"MJ Chen","year":"2016","unstructured":"Chen, M. J. et al. Statins and the risk of pancreatic cancer in Type 2 diabetic patients\u2013A population-based cohort study. International journal of cancer \n                           138, 594\u2013603, https:\/\/doi.org\/10.1002\/ijc.29813 (2016).","journal-title":"International journal of cancer"},{"key":"13430_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.14423\/SMJ.0000000000000423","volume":"109","author":"JM Backes","year":"2016","unstructured":"Backes, J. M., Kostoff, M. D., Gibson, C. A. & Ruisinger, J. F. Statin-Associated Diabetes Mellitus: Review and Clinical Guide. Southern medical journal \n                           109, 167\u2013173, https:\/\/doi.org\/10.14423\/SMJ.0000000000000423 (2016).","journal-title":"Southern medical journal"},{"key":"13430_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala, R., Basu, A., Petersen, G. M. & Chari, S. T. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. The Lancet. Oncology \n                           10, 88\u201395, https:\/\/doi.org\/10.1016\/S1470-2045(08)70337-1 (2009).","journal-title":"The Lancet. Oncology"},{"key":"13430_CR40","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1158\/1055-9965.EPI-13-1284","volume":"23","author":"SA Streicher","year":"2014","unstructured":"Streicher, S. A., Yu, H., Lu, L., Kidd, M. S. & Risch, H. A. Case-control study of aspirin use and risk of pancreatic cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology \n                           23, 1254\u20131263, https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-1284 (2014).","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"13430_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jnci\/djh001","volume":"96","author":"ES Schernhammer","year":"2004","unstructured":"Schernhammer, E. S. et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. Journal of the National Cancer Institute \n                           96, 22\u201328 (2004).","journal-title":"Journal of the National Cancer Institute"},{"key":"13430_CR42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1365-2036.2007.03495.x","volume":"26","author":"G Capurso","year":"2007","unstructured":"Capurso, G. et al. Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Alimentary pharmacology & therapeutics \n                           26, 1089\u20131099, https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03495.x (2007).","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"13430_CR43","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mc.21916","volume":"52","author":"J Liao","year":"2013","unstructured":"Liao, J. et al. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice. Molecular carcinogenesis \n                           52, 739\u2013750, https:\/\/doi.org\/10.1002\/mc.21916 (2013).","journal-title":"Molecular carcinogenesis"},{"key":"13430_CR44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/003591576505800503","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill, A. B. The Environment and Disease: Association or Causation? Proceedings of the Royal Society of Medicine \n                           58, 295\u2013300 (1965).","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"13430_CR45","first-page":"57","volume":"11","author":"S Lewallen","year":"1998","unstructured":"Lewallen, S. & Courtright, P. Epidemiology in practice: case-control studies. Community eye health\/International Centre for Eye Health \n                           11, 57\u201358 (1998).","journal-title":"Community eye health\/International Centre for Eye Health"},{"key":"13430_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102146","volume":"9","author":"C Ferrajolo","year":"2014","unstructured":"Ferrajolo, C. et al. Pattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment? PloS one \n                           9, e102146, https:\/\/doi.org\/10.1371\/journal.pone.0102146 (2014).","journal-title":"PloS one"},{"key":"13430_CR47","unstructured":"(ISTAT), I. N. d. S. http:\/\/dati.istat.it\/Index.aspx?DataSetCode (Date of access:15\/06\/2017) (2016)."},{"key":"13430_CR48","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1111\/j.1572-0241.2007.01510.x","volume":"102","author":"MM Hassan","year":"2007","unstructured":"Hassan, M. M. et al. Risk factors for pancreatic cancer: case-control study. The American journal of gastroenterology \n                           102, 2696\u20132707, https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01510.x (2007).","journal-title":"The American journal of gastroenterology"},{"key":"13430_CR49","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.3748\/wjg.v21.i12.3711","volume":"21","author":"J Wang","year":"2015","unstructured":"Wang, J., Wang, W. J., Zhai, L. & Zhang, D. F. Association of cholesterol with risk of pancreatic cancer: a meta-analysis. World journal of gastroenterology \n                           21, 3711\u20133719, https:\/\/doi.org\/10.3748\/wjg.v21.i12.3711 (2015).","journal-title":"World journal of gastroenterology"},{"key":"13430_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MPA.0000000000000470","volume":"45","author":"MM Kozak","year":"2016","unstructured":"Kozak, M. M. et al. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer. Pancreas \n                           45, 64\u201370, https:\/\/doi.org\/10.1097\/MPA.0000000000000470 (2016).","journal-title":"Pancreas"},{"key":"13430_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121783","volume":"10","author":"CY Jeon","year":"2015","unstructured":"Jeon, C. Y. et al. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. PloS one \n                           10, e0121783, https:\/\/doi.org\/10.1371\/journal.pone.0121783 (2015).","journal-title":"PloS one"},{"key":"13430_CR52","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/ajg.2015.217","volume":"110","author":"BU Wu","year":"2015","unstructured":"Wu, B. U. et al. Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. The American journal of gastroenterology \n                           110, 1233\u20131239, https:\/\/doi.org\/10.1038\/ajg.2015.217 (2015).","journal-title":"The American journal of gastroenterology"},{"key":"13430_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/474905","volume":"2014","author":"M Distler","year":"2014","unstructured":"Distler, M., Aust, D., Weitz, J., Pilarsky, C. & Grutzmann, R. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. BioMed research international \n                           2014, 474905, https:\/\/doi.org\/10.1155\/2014\/474905 (2014).","journal-title":"BioMed research international"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13430-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13430-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13430-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:50:23Z","timestamp":1671796223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13430-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13430-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]},"assertion":[{"value":"10 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13024"}}